Robert Heimer, PhD

• Amy Justice
• Daniel Zelterman
• David Fiellin
• Edward Kaplan
• Erol Fikrig
• Frederick Lewis Altice
• Gail D'Onofrio
• James Meek
• Jeanette Tetrault
• Kaveh Khoshnood
• Kimberly Yousey-Hindes
• Lauretta Grau
• Linda Niccolai
• Robert Dubrow
• Russell Barbour
• Tassos C. Kyriakides

Acquired Immunodeficiency Syndrome; Epidemiology; Foodborne Diseases; Hepatitis C; Injections; Public Health; Russia; Vietnam; Global Health; HIV Infections

HIV/AIDS; Infectious Diseases; Substance Use, Addiction; COVID-19

• Technical violations and infractions are drivers of disengagement from methadone treatment among people with opioid use disorder discharged from Connecticut jails 2014–2018Marotta P, Hass A, Viera A, Doernberg M, Barbour R, Grau L, Heimer R. Technical violations and infractions are drivers of disengagement from methadone treatment among people with opioid use disorder discharged from Connecticut jails 2014–2018 Substance Abuse Treatment, Prevention, And Policy 2023, 18: 43. PMID: 37420271, PMCID: PMC10329353, DOI: 10.1186/s13011-023-00541-2.
• Concordance between controlled substance receipt and post-mortem toxicology in opioid-detected overdose deaths: A statewide analysisHowell B, Black A, Grau L, Lin H, Greene C, Lee H, Heimer R, Hawk K, D'Onofrio G, Fiellin D, Becker W. Concordance between controlled substance receipt and post-mortem toxicology in opioid-detected overdose deaths: A statewide analysis Drug And Alcohol Dependence 2023, 244: 109788. PMID: 36738634, PMCID: PMC9975083, DOI: 10.1016/j.drugalcdep.2023.109788.
• Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in MalaysiaBazazi A, Culbert G, Wegman M, Heimer R, Kamarulzaman A, Altice F. Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia BMC Infectious Diseases 2022, 22: 837. PMID: 36368939, PMCID: PMC9652918, DOI: 10.1186/s12879-022-07804-6.
• 168 Impact of Connecticut’s Good Samaritan Laws in Preventing Opioid Overdose Deaths – An Applied System Dynamics ApproachAli S, Sabounchi N, Thompson R, Heimer R, D’Onofrio G, Heckmann R. 168 Impact of Connecticut’s Good Samaritan Laws in Preventing Opioid Overdose Deaths – An Applied System Dynamics Approach Annals Of Emergency Medicine 2022, 80: s76-s77. DOI: 10.1016/j.annemergmed.2022.08.192.
• Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infectionViera A, Grau L, Fisher J, Farnum S, Tetrault J, Scott G, Heimer R. Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection Drug And Alcohol Dependence Reports 2022, 3: 100038. DOI: 10.1016/j.dadr.2022.100038.
• Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infectionViera A, Grau L, Fisher J, Farnum S, Tetrault J, Scott G, Heimer R. Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection Drug And Alcohol Dependence Reports 2022, 3: 100038. PMID: 36845980, PMCID: PMC9948939, DOI: 10.1016/j.dadr.2022.100038.
• Reported history and correlates of drug overdose among people who inject drugs in LebanonKhoshnood K, Sheb F, Khouri D, Aaraj E, Barbour R, Crawford F, Mokhbat J, Parpia A, Heimer R. Reported history and correlates of drug overdose among people who inject drugs in Lebanon Eastern Mediterranean Health Journal 2021, 27: 571-579. DOI: 10.26719/2021.27.6.571.
• Co-Located hepatitis C virus infection treatment within an opioid treatment program promotes opioid agonist treatment retentionSevere B, Tetrault JM, Madden L, Heimer R. Co-Located hepatitis C virus infection treatment within an opioid treatment program promotes opioid agonist treatment retention Drug And Alcohol Dependence 2020, 213: 108116. PMID: 32599493, DOI: 10.1016/j.drugalcdep.2020.108116.
• Physician and patient prediction of adherence to antiretroviral therapy in HIV positive people in Saint-Petersburg, RussiaVetrova M, Aleksandrova O, Paschenko A, Toropov S, Rassokhin V, Abyshev R, Levina O, Niccolai L, Heimer R. Physician and patient prediction of adherence to antiretroviral therapy in HIV positive people in Saint-Petersburg, Russia AIDS Care 2020, 33: 473-477. PMID: 32148065, DOI: 10.1080/09540121.2020.1738005.
• Early stages of HIV treatment cascade in people living with HIV in Saint-Petersburg, RussiaVetrova M, Aleksandrova O, Paschenko A, Toropov S, Rassokhin V, Abyshev R, Levina O, Niccolai L, Heimer R. Early stages of HIV treatment cascade in people living with HIV in Saint-Petersburg, Russia AIDS Care 2018, 30: 857-862. PMID: 29325435, DOI: 10.1080/09540121.2017.1417536.
• Sex Work, Injection Drug Use, and Abscesses: Associations in Women, But Not MenBurke D, Wurcel A, Landy D, Skeer M, Heimer R, Chui K, Stopka T. Sex Work, Injection Drug Use, and Abscesses: Associations in Women, But Not Men Open Forum Infectious Diseases 2017, 4: s109-s109. PMCID: PMC5632174, DOI: 10.1093/ofid/ofx163.113.
• P.3.028 Treatment outcomes of newly initiated antiretroviral therapy in HIV-infected people in Saint-Petersburg, RussiaVetrova M, Heimer R, Niccolai L, Aleksandrova O, Paschenko A, Toropov S. P.3.028 Treatment outcomes of newly initiated antiretroviral therapy in HIV-infected people in Saint-Petersburg, Russia European Neuropsychopharmacology 2016, 26: s71-s72. DOI: 10.1016/s0924-977x(16)70078-2.
• Psychiatric Distress, Drug Use, and HIV Viral Load Suppression in RussiaUstinov A, Suvorova A, Belyakov A, Makhamatova A, Levina O, Krupitsky E, Lioznov D, Niccolai L, Heimer R. Psychiatric Distress, Drug Use, and HIV Viral Load Suppression in Russia AIDS And Behavior 2016, 20: 1603-1608. PMID: 26809193, PMCID: PMC4945434, DOI: 10.1007/s10461-016-1297-x.
• THE CRITICAL ASPECTS OF THE EARLY STAGES OF ANTIRETROVIRAL THERAPY PROVISION TO HIV PATIENTSVetrova M, Aleksandrova O, Paschenko A, Toropov S, Abyshev P, Levina O, Belyakov A, Rassokhin V, Niccolai L, Heimer R. THE CRITICAL ASPECTS OF THE EARLY STAGES OF ANTIRETROVIRAL THERAPY PROVISION TO HIV PATIENTS HIV Infection And Immunosuppressive Disorders 2016, 8: 27-37. DOI: 10.22328/2077-9828-2016-8-4-27-37.
• P61 Psychosocial determinants of HIV disclosure to confidants with different HIV statusMakhamatova A, Suvorova A, Belyakov A, Ustinov A, Levina O, Heimer R. P61 Psychosocial determinants of HIV disclosure to confidants with different HIV status Sexually Transmitted Infections 2015, 91: a35-a36. DOI: 10.1136/sextrans-2015-052126.104.
• Post-incarceration factors and relapse to opioid injection in St. Petersburg, RussiaCepeda J, Lyubimova A, Levina O, Heimer R. Post-incarceration factors and relapse to opioid injection in St. Petersburg, Russia Drug And Alcohol Dependence 2015, 146: e243. DOI: 10.1016/j.drugalcdep.2014.09.128.
• Processing length bias of time intervals between the last episode and the interview in Gamma-Poisson models of behaviorZelterman D, Suvorova A, Paschenko A, Musina V, Tulupyev A, Tulupyeva T, Krasnoselskikh T, Grau L, Heimer R. Processing length bias of time intervals between the last episode and the interview in Gamma-Poisson models of behavior SPIIRAS Proceedings 2014, 1: 160-185. DOI: 10.15622/sp.16.6.
• Regression diagnostics in the rate analysis based on data about the last episodesZelterman D, Suvorova A, Paschenko A, Musina V, Tulupyev A, Tulupyeva T, Grau L, Heimer R. Regression diagnostics in the rate analysis based on data about the last episodes SPIIRAS Proceedings 2014, 2: 33-46. DOI: 10.15622/sp.17.2.
• P3.133 Potential HIV Transmissions from Infected Drug Injectors and Men Who Have Sex with Men in Saint Petersburg, RussiaWhite E, Niccolai L, Toussova O, Verevochkin S, Kozlov A, Heimer R. P3.133 Potential HIV Transmissions from Infected Drug Injectors and Men Who Have Sex with Men in Saint Petersburg, Russia Sexually Transmitted Infections 2013, 89: a189. DOI: 10.1136/sextrans-2013-051184.0592.
• P3.225 HSV-2 Seroprevalence Among Current Injection Drug Users in EstoniaUusküla A, Raag M, Abel-Ollo K, Talu A, Rüütel K, Salekesin M, Niccolai L, White T, Heimer R. P3.225 HSV-2 Seroprevalence Among Current Injection Drug Users in Estonia Sexually Transmitted Infections 2013, 89: a218. DOI: 10.1136/sextrans-2013-051184.0682.
• Speaking the truth: an analysis of gender differences in serostatus disclosure practices among HIV-infected patients in St Petersburg, RussiaDavidson A, Zaller N, Dukhovlinova E, Toussova O, Feller E, Heimer R, Kozlov A. Speaking the truth: an analysis of gender differences in serostatus disclosure practices among HIV-infected patients in St Petersburg, Russia International Journal Of STD & AIDS 2012, 23: 685-688. PMID: 23104740, DOI: 10.1258/ijsa.2012.011463.
• Sexual Partners of Street-Based Female Sex Workers in St. Petersburg, Russia: A Model of Partnership Characteristics as a Basis for Further ResearchLevina OS, Heimer R, Odinokova V, Bodanovskaya Z, Safiullina L, Irwin KS, Niccolai LM. Sexual Partners of Street-Based Female Sex Workers in St. Petersburg, Russia: A Model of Partnership Characteristics as a Basis for Further Research Human Organization 2012, 71: 32-43. PMID: 25741032, PMCID: PMC4346184, DOI: 10.17730/humo.71.1.9130380u68614w47.
• Chronic pain, Addiction severity, and misuse of opioids in Cumberland County, MaineHeimer R, Dasgupta N, Irwin KS, Kinzly M, Harvey AP, Givens A, Grau LE. Chronic pain, Addiction severity, and misuse of opioids in Cumberland County, Maine Addictive Behaviors 2011, 37: 346-349. PMID: 22138379, DOI: 10.1016/j.addbeh.2011.11.017.
• Police training to align law enforcement and HIV prevention: preliminary evidence from the field.Beletsky L, Agrawal A, Moreau B, Kumar P, Weiss-Laxer N, Heimer R. Police training to align law enforcement and HIV prevention: preliminary evidence from the field. American Journal Of Public Health 2011, 101: 2012-5. PMID: 21940924, PMCID: PMC3222387, DOI: 10.2105/ajph.2011.300254.
• P1-S2.05 Clients of street-based female sex workers and potential bridging of HIV/STI in RussiaNiccolai L, Odinokova V, Safiullina L, Bodanovskaya Z, Heimer R, Levina O, Rusakova M. P1-S2.05 Clients of street-based female sex workers and potential bridging of HIV/STI in Russia Sexually Transmitted Infections 2011, 87: a124. DOI: 10.1136/sextrans-2011-050108.62.
• Prevalence, characteristics, and predictors of police training initiatives by US SEPs: Building an evidence base for structural interventionsBeletsky L, Grau LE, White E, Bowman S, Heimer R. Prevalence, characteristics, and predictors of police training initiatives by US SEPs: Building an evidence base for structural interventions Drug And Alcohol Dependence 2011, 119: 145-149. PMID: 21705159, PMCID: PMC3192926, DOI: 10.1016/j.drugalcdep.2011.05.034.
• Subpopulations of Illicit Drug Users Reached by Targeted Street Outreach and Respondent-Driven Sampling Strategies: Implications for Research and Public Health PracticeRudolph AE, Crawford ND, Latkin C, Heimer R, Benjamin EO, Jones KC, Fuller CM. Subpopulations of Illicit Drug Users Reached by Targeted Street Outreach and Respondent-Driven Sampling Strategies: Implications for Research and Public Health Practice Annals Of Epidemiology 2011, 21: 280-289. PMID: 21376275, PMCID: PMC3062521, DOI: 10.1016/j.annepidem.2010.11.007.
• Practices and Attitudes of Addiction Treatment Providers in the Russian FederationTorban M, Heimer R, D. Ilyuk R, Krupitsky E. Practices and Attitudes of Addiction Treatment Providers in the Russian Federation Journal Of Addiction Research & Therapy 2011, 02 DOI: 10.4172/2155-6105.1000104.
• Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997–2007Green TC, Grau LE, Carver HW, Kinzly M, Heimer R. Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997–2007 Drug And Alcohol Dependence 2010, 115: 221-228. PMID: 21131140, PMCID: PMC3095753, DOI: 10.1016/j.drugalcdep.2010.11.007.
• Comparing sexual risks and patterns of alcohol and drug use between injection drug users (IDUs) and non-IDUs who report sexual partnerships with IDUs in St. Petersburg, RussiaAbdala N, White E, Toussova OV, Krasnoselskikh TV, Verevochkin S, Kozlov AP, Heimer R. Comparing sexual risks and patterns of alcohol and drug use between injection drug users (IDUs) and non-IDUs who report sexual partnerships with IDUs in St. Petersburg, Russia BMC Public Health 2010, 10: 676. PMID: 21054855, PMCID: PMC2988741, DOI: 10.1186/1471-2458-10-676.
• The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programsBeletsky L, Grau LE, White E, Bowman S, Heimer R. The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs Addiction 2010, 106: 357-365. PMID: 21054615, PMCID: PMC3088513, DOI: 10.1111/j.1360-0443.2010.03149.x.
• The Relative Role of Perceived Partner Risks in Promoting Condom Use in a Three-City Sample of High-Risk, Low-Income WomenOber AJ, Iguchi MY, Weiss RE, Gorbach PM, Heimer R, Ouellet LJ, Shoptaw S, Anglin MD, Zule WA. The Relative Role of Perceived Partner Risks in Promoting Condom Use in a Three-City Sample of High-Risk, Low-Income Women AIDS And Behavior 2010, 15: 1347-1358. PMID: 20976538, PMCID: PMC3180610, DOI: 10.1007/s10461-010-9840-7.
• Malignancies in HIVBelyakov N, Zagdyn Z, Rassochin V, Trofimova T, Kovelenov A, Dubrow R, Heimer R. Malignancies in HIV Infectious Agents And Cancer 2010, 5: a52. PMCID: PMC3002713, DOI: 10.1186/1750-9378-5-s1-a52.
• Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug UsersPaintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users The Journal Of Infectious Diseases 2010, 202: 984-990. PMID: 20726768, PMCID: PMC2932767, DOI: 10.1086/656212.
• Drug Network Characteristics and HIV Risk Among Injection Drug Users in Russia: The roles of Trust, Size, and StabilityCepeda JA, Odinokova VA, Heimer R, Grau LE, Lyubimova A, Safiullina L, Levina OS, Niccolai LM. Drug Network Characteristics and HIV Risk Among Injection Drug Users in Russia: The roles of Trust, Size, and Stability AIDS And Behavior 2010, 15: 1003-1010. PMID: 20872063, PMCID: PMC3112286, DOI: 10.1007/s10461-010-9816-7.
• Estimates of HIV incidence among drug users in St. Petersburg, Russia: continued growth of a rapidly expanding epidemicNiccolai LM, Verevochkin SV, Toussova OV, White E, Barbour R, Kozlov AP, Heimer R. Estimates of HIV incidence among drug users in St. Petersburg, Russia: continued growth of a rapidly expanding epidemic European Journal Of Public Health 2010, 21: 613-619. PMID: 20798184, PMCID: PMC3180633, DOI: 10.1093/eurpub/ckq115.
• HIV Disclosure, Condom Use, and Awareness of HIV Infection Among HIV-Positive, Heterosexual Drug Injectors in St. Petersburg, Russian FederationGrau LE, White E, Niccolai LM, Toussova OV, Verevochkin SV, Kozlov AP, Heimer R. HIV Disclosure, Condom Use, and Awareness of HIV Infection Among HIV-Positive, Heterosexual Drug Injectors in St. Petersburg, Russian Federation AIDS And Behavior 2010, 15: 45-57. PMID: 20700645, PMCID: PMC3023022, DOI: 10.1007/s10461-010-9775-z.
• Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policiesGreen TC, Bluthenthal RN, Singer M, Beletsky L, Grau LE, Marshall P, Heimer R. Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies Drug And Alcohol Dependence 2010, 111: 74-81. PMID: 20537814, PMCID: PMC3087197, DOI: 10.1016/j.drugalcdep.2010.03.022.
• Patterns of drug use and abuse among aging adults with and without HIV: A latent class analysis of a US Veteran cohortGreen TC, Kershaw T, Lin H, Heimer R, Goulet JL, Kraemer KL, Gordon AJ, Maisto SA, Day NL, Bryant K, Fiellin DA, Justice AC. Patterns of drug use and abuse among aging adults with and without HIV: A latent class analysis of a US Veteran cohort Drug And Alcohol Dependence 2010, 110: 208-220. PMID: 20395074, PMCID: PMC3087206, DOI: 10.1016/j.drugalcdep.2010.02.020.
• Estimation of the number of injection drug users in St. Petersburg, RussiaHeimer R, White E. Estimation of the number of injection drug users in St. Petersburg, Russia Drug And Alcohol Dependence 2010, 109: 79-83. PMID: 20060238, PMCID: PMC2875272, DOI: 10.1016/j.drugalcdep.2009.12.010.
• [The study of characteristics of overdose among users of opioid drug injections].Iliuk R, Krupitskiĭ E, Torban M, Kozlov A, Blinnikova K, Heimer R, Green T, Grau L. [The study of characteristics of overdose among users of opioid drug injections]. Zhurnal Nevrologii I Psikhiatrii Im S S Korsakova 2010, 110: 33-43. PMID: 21322146.
• Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug usersGrau LE, Green TC, Singer M, Bluthenthal RN, Marshall PA, Heimer R. Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug users Harm Reduction Journal 2009, 6: 36. PMID: 20003518, PMCID: PMC2804675, DOI: 10.1186/1477-7517-6-36.
• Statistical design for a small serial dilution seriesZelterman D, Tulupyev A, Heimer R, Abdala N. Statistical design for a small serial dilution series Statistics In Medicine 2009, 29: 411-420. PMID: 19943329, PMCID: PMC3113538, DOI: 10.1002/sim.3774.
• Peridomestic Lyme Disease Prevention Results of a Population-Based Case–Control StudyConnally NP, Durante AJ, Yousey-Hindes KM, Meek JI, Nelson RS, Heimer R. Peridomestic Lyme Disease Prevention Results of a Population-Based Case–Control Study American Journal Of Preventive Medicine 2009, 37: 201-206. PMID: 19595558, DOI: 10.1016/j.amepre.2009.04.026.
• Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infectionPaintsil E, Verevochkin SV, Dukhovlinova E, Niccolai L, Barbour R, White E, Toussova OV, Alexander L, Kozlov AP, Heimer R. Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection Addiction 2009, 104: 1881-1890. PMID: 19712125, PMCID: PMC2763027, DOI: 10.1111/j.1360-0443.2009.02687.x.
• Drug choice, spatial distribution, HIV risk, and HIV prevalence among injection drug users in St. Petersburg, RussiaKruse GR, Barbour R, Heimer R, Shaboltas AV, Toussova OV, Hoffman IF, Kozlov AP. Drug choice, spatial distribution, HIV risk, and HIV prevalence among injection drug users in St. Petersburg, Russia Harm Reduction Journal 2009, 6: 22. PMID: 19646255, PMCID: PMC2731096, DOI: 10.1186/1477-7517-6-22.
• Psychosocial and contextual correlates of opioid overdose risk among drug users in St. Petersburg, RussiaGrau LE, Green TC, Torban M, Blinnikova K, Krupitsky E, Ilyuk R, Kozlov AP, Heimer R. Psychosocial and contextual correlates of opioid overdose risk among drug users in St. Petersburg, Russia Harm Reduction Journal 2009, 6: 17. PMID: 19630963, PMCID: PMC2724502, DOI: 10.1186/1477-7517-6-17.
• Potential Bridges of Heterosexual HIV Transmission from Drug Users to the General Population in St. Petersburg, Russia: Is it Easy to be a Young Female?Toussova O, Shcherbakova I, Volkova G, Niccolai L, Heimer R, Kozlov A. Potential Bridges of Heterosexual HIV Transmission from Drug Users to the General Population in St. Petersburg, Russia: Is it Easy to be a Young Female? Journal Of Urban Health 2009, 86: 121-130. PMID: 19533368, PMCID: PMC2705483, DOI: 10.1007/s11524-009-9364-5.
• The Potential for Bridging of HIV Transmission in the Russian Federation: Sex Risk Behaviors and HIV Prevalence among Drug Users (DUs) and their Non-DU Sex PartnersNiccolai LM, Shcherbakova IS, Toussova OV, Kozlov AP, Heimer R. The Potential for Bridging of HIV Transmission in the Russian Federation: Sex Risk Behaviors and HIV Prevalence among Drug Users (DUs) and their Non-DU Sex Partners Journal Of Urban Health 2009, 86: 131-143. PMID: 19507037, PMCID: PMC2705488, DOI: 10.1007/s11524-009-9369-0.
• Simultaneous Recruitment of Drug Users and Men Who Have Sex with Men in the United States and Russia Using Respondent-Driven Sampling: Sampling Methods and ImplicationsIguchi MY, Ober AJ, Berry SH, Fain T, Heckathorn DD, Gorbach PM, Heimer R, Kozlov A, Ouellet LJ, Shoptaw S, Zule WA. Simultaneous Recruitment of Drug Users and Men Who Have Sex with Men in the United States and Russia Using Respondent-Driven Sampling: Sampling Methods and Implications Journal Of Urban Health 2009, 86: 5. PMID: 19472058, PMCID: PMC2705484, DOI: 10.1007/s11524-009-9365-4.
• High HIV Prevalence, Suboptimal HIV Testing, and Low Knowledge of HIV-Positive Serostatus Among Injection Drug Users in St. Petersburg, RussiaNiccolai LM, Toussova OV, Verevochkin SV, Barbour R, Heimer R, Kozlov AP. High HIV Prevalence, Suboptimal HIV Testing, and Low Knowledge of HIV-Positive Serostatus Among Injection Drug Users in St. Petersburg, Russia AIDS And Behavior 2008, 14: 932-941. PMID: 18843531, PMCID: PMC3116648, DOI: 10.1007/s10461-008-9469-y.
• Social and structural aspects of the overdose risk environment in St. Petersburg, RussiaGreen TC, Grau LE, Blinnikova KN, Torban M, Krupitsky E, Ilyuk R, Kozlov A, Heimer R. Social and structural aspects of the overdose risk environment in St. Petersburg, Russia International Journal Of Drug Policy 2008, 20: 270-276. PMID: 18774283, PMCID: PMC2696401, DOI: 10.1016/j.drugpo.2008.07.002.
• Economic Evaluation of Delivering Hepatitis B Vaccine to Injection Drug UsersHu Y, Grau LE, Scott G, Seal KH, Marshall PA, Singer M, Heimer R. Economic Evaluation of Delivering Hepatitis B Vaccine to Injection Drug Users American Journal Of Preventive Medicine 2008, 35: 25-32. PMID: 18541174, PMCID: PMC2483306, DOI: 10.1016/j.amepre.2008.03.028.
• Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United StatesGreen TC, Heimer R, Grau LE. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States Addiction 2008, 103: 979-989. PMID: 18422830, PMCID: PMC3163671, DOI: 10.1111/j.1360-0443.2008.02182.x.
• Community coverage and HIV prevention: Assessing metrics for estimating HIV incidence through syringe exchangeHeimer R. Community coverage and HIV prevention: Assessing metrics for estimating HIV incidence through syringe exchange International Journal Of Drug Policy 2008, 19: 65-73. PMID: 18207726, PMCID: PMC2367433, DOI: 10.1016/j.drugpo.2007.12.004.
• Spatial distribution of HIV prevalence and incidence among injection drugs users in St Petersburg: implications for HIV transmissionHeimer R, Barbour R, Shaboltas AV, Hoffman IF, Kozlov AP. Spatial distribution of HIV prevalence and incidence among injection drugs users in St Petersburg: implications for HIV transmission AIDS 2008, 22: 123-130. PMID: 18090400, PMCID: PMC2778790, DOI: 10.1097/qad.0b013e3282f244ef.
• Hepatitis B Virus Prevalence and Vaccination Rates among Hispanic Injection Drug Users Participating in a Vaccination CampaignHeimer R, Grau L, Singer M, Scott G, Marshall P, Hu Y, Seal K. Hepatitis B Virus Prevalence and Vaccination Rates among Hispanic Injection Drug Users Participating in a Vaccination Campaign Journal Of Drug Issues 2008, 38: 335-350. DOI: 10.1177/002204260803800114.
• CHAPTER 67 The Role of Unsterile Injections in the HIV PandemicDrucker E, Apetrei C, Heimer R, Marx P. CHAPTER 67 The Role of Unsterile Injections in the HIV Pandemic 2008, 755-767. DOI: 10.1016/b978-1-4160-2882-6.50071-x.
• Illicit Use of Opioids: Is OxyContin® a “Gateway Drug”?Grau LE, Dasgupta N, Grau L, Dasgupta N, Harvey A, Grau L, Dasgupta N, Harvey A, Irwin K, Givens‡ A, Grau L, Dasgupta N, Harvey A, Irwin K, Givens‡ A, Kinzly M, Heimer R. Illicit Use of Opioids: Is OxyContin® a “Gateway Drug”? American Journal On Addictions 2007, 16: 166-173. PMID: 17612819, DOI: 10.1080/10550490701375293.
• HIV and Drug Use in EurasiaHeimer R, Booth R, Irwin K, Merson M. HIV and Drug Use in Eurasia 2006, 141-163. DOI: 10.1057/9780230603394_8.
• Lessons from the Field: From Research to Application in the Fight Against AIDS among Injection Drug Users in Three New England CitiesSinger M, Stopka T, Shaw S, Santelices C, Buchanon D, Teng W, Khooshnood K, Heimer R. Lessons from the Field: From Research to Application in the Fight Against AIDS among Injection Drug Users in Three New England Cities Human Organization 2005, 64: 179-191. DOI: 10.17730/humo.64.2.ga5ebpqynpxayrb5.
• Methadone Maintenance in a Men’s Prison in Puerto Rico: A Pilot ProgramHeimer R, Catania H, Zambrano J, Brunet A, Ortiz A, Newman R. Methadone Maintenance in a Men’s Prison in Puerto Rico: A Pilot Program Journal Of Correctional Health Care 2005, 11: 295-305. DOI: 10.1177/107834580401100307.
• MAINTAINING RESPECTABILITY AND RESPONSIBILITY: GENDERED LABOR PATTERNS AMONG WOMEN INJECTION DRUG USERSHofman N, Strenski T, Marshall P, Heimer R. MAINTAINING RESPECTABILITY AND RESPONSIBILITY: GENDERED LABOR PATTERNS AMONG WOMEN INJECTION DRUG USERS Health Care For Women International 2003, 24: 794-807. PMID: 14742117, DOI: 10.1080/07399330390229966.
• Model phobia: looking past the curvesHeimer R. Model phobia: looking past the curves International Journal Of Drug Policy 2003, 14: 87-88. DOI: 10.1016/s0955-3959(02)00213-x.
• Structural interventions to improve opiate maintenanceHeimer R, Bray S, Burris S, Khoshnood K, Blankenship K. Structural interventions to improve opiate maintenance International Journal Of Drug Policy 2002, 13: 103-111. DOI: 10.1016/s0955-3959(02)00009-9.
• Can HIV-1-Contaminated Syringes Be Disinfected?Abdala N, Gleghorn A, Carney J, Heimer R. Can HIV-1-Contaminated Syringes Be Disinfected? JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 487-494. DOI: 10.1097/00126334-200112150-00013.
• Can HIV-1-Contaminated Syringes Be Disinfected?: Implications for Transmission Among Injection Drug Users.Abdala N, Gleghorn A, Carney J, Heimer R. Can HIV-1-Contaminated Syringes Be Disinfected?: Implications for Transmission Among Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 487. PMID: 11744839, DOI: 10.1097/00042560-200112150-00013.
• Development and Application of a Genotypic AZT Resistance Assay: Quantitative Assessment of the Resistance Profile of Clinical Samples and the Relative Predictive Ability of a Resistance Index.Kyriakides TC, Heimer RR. Development and Application of a Genotypic AZT Resistance Assay: Quantitative Assessment of the Resistance Profile of Clinical Samples and the Relative Predictive Ability of a Resistance Index. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 211. PMID: 11694826, DOI: 10.1097/00042560-200111010-00002.
• Development and Application of a Genotypic AZT Resistance AssayKyriakides T, Heimer R. Development and Application of a Genotypic AZT Resistance Assay JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 211-220. DOI: 10.1097/00126334-200111010-00002.
• Doffing the cap: increasing syringe availability by law but not in practice, Connecticut, 1999Bray S, Lawson J, Heimer R. Doffing the cap: increasing syringe availability by law but not in practice, Connecticut, 1999 International Journal Of Drug Policy 2001, 12: 221-235. DOI: 10.1016/s0955-3959(01)00078-0.
• Viability of HIV-1 in syringes: implications for interventions among injection drug users.Heimer R, Abdala N. Viability of HIV-1 in syringes: implications for interventions among injection drug users. The AIDS Reader 2000, 10: 410-7. PMID: 10932845.
• Survival of HIV-1 in Syringes: Effects of Temperature during StorageAbdala N, Reyes R, Carney J, Heimer R. Survival of HIV-1 in Syringes: Effects of Temperature during Storage Substance Use & Misuse 2000, 35: 1369-1383. PMID: 10921429, DOI: 10.3109/10826080009148220.
• HIV-1 Transmission in Injection Paraphernalia: Heating Drug Solutions May Inactivate HIV-1Clatts M, Heimer R, Abdala N, Goldsamt L, Sotheran J, Anderson K, Gallo T, Hoffer L, Luciano P, Kyriakides T. HIV-1 Transmission in Injection Paraphernalia: Heating Drug Solutions May Inactivate HIV-1 JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 22: 194-199. PMID: 10843535, DOI: 10.1097/00126334-199910010-00013.
• HIV-1 Transmission in Injection Paraphernalia: Heating Drug Solutions May Inactivate HIV-1Clatts M, Heimer R, Abdala N, Goldsamt L, Sotheran J, Anderson K, Gallo T, Hoffer L, Luciano P, Kyriakides T. HIV-1 Transmission in Injection Paraphernalia: Heating Drug Solutions May Inactivate HIV-1 JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 22: 194. DOI: 10.1097/00042560-199910010-00013.
• Serologic testing of horses for granulocytic ehrlichiosis, using indirect fluorescent antibody staining and immunoblot analysis.Magnarelli LA, Van Andel AE, Ijdo JW, Heimer R, Fikrig E. Serologic testing of horses for granulocytic ehrlichiosis, using indirect fluorescent antibody staining and immunoblot analysis. American Journal Of Veterinary Research 1999, 60: 631-5. PMID: 10328436.
• Survival of HIV-1 in SyringesAbdala N, Stephens C, Griffith B, Heimer R. Survival of HIV-1 in Syringes JAIDS Journal Of Acquired Immune Deficiency Syndromes 1999, 20: 73-80. PMID: 9928733, DOI: 10.1097/00042560-199901010-00011.
• Reactivity of Human Sera to Different Strains of Granulocytic Ehrlichiae in Immunodiagnostic AssaysMagnarelli L, IJdo J, Dumler J, Heimer R, Fikrig E. Reactivity of Human Sera to Different Strains of Granulocytic Ehrlichiae in Immunodiagnostic Assays The Journal Of Infectious Diseases 1998, 178: 1835-1838. PMID: 9815246, DOI: 10.1086/314516.
• Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injectionRich J, Dickinson B, Carney J, Fisher A, Heimer R. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection AIDS 1998, 12: 2345-2350. PMID: 9863878, DOI: 10.1097/00002030-199817000-00017.
• Development and duration of antibody response against Ehrlichia equi in horses.Van Andel A, Magnarelli L, Heimer R, Wilson M. Development and duration of antibody response against Ehrlichia equi in horses. Journal Of The American Veterinary Medical Association 1998, 212: 1910-4. PMID: 9638192.
• A single tissue culture system for the propagation of the agents of the human ehrlichioses.Heimer R, Tisdale D, Dawson J. A single tissue culture system for the propagation of the agents of the human ehrlichioses. American Journal Of Tropical Medicine And Hygiene 1998, 58: 812-5. PMID: 9660470, DOI: 10.4269/ajtmh.1998.58.812.
• Can Syringe Exchange Serve as a Conduit to Substance Abuse Treatment?Heimer R. Can Syringe Exchange Serve as a Conduit to Substance Abuse Treatment? Journal Of Substance Abuse Treatment 1998, 15: 183-191. PMID: 9633030, DOI: 10.1016/s0740-5472(97)00220-1.
• Syringe Use and Reuse: Effects of Syringe Exchange Programs in Four CitiesHeimer R, Khoshnood K, Bigg D, Guydish J, Junge B. Syringe Use and Reuse: Effects of Syringe Exchange Programs in Four Cities JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: s37-s44. PMID: 9663622, DOI: 10.1097/00042560-199802001-00008.
• Propagation of granulocytic Ehrlichia spp. from human and equine sources in HL-60 cells induced to differentiate into functional granulocytes.Heimer R, Van Andel A, Wormser G, Wilson M. Propagation of granulocytic Ehrlichia spp. from human and equine sources in HL-60 cells induced to differentiate into functional granulocytes. Journal Of Clinical Microbiology 1997, 35: 923-7. PMID: 9157154, PMCID: PMC229702, DOI: 10.1128/jcm.35.4.923-927.1997.
• HIV Incidence Among New Haven Needle Exchange ParticipantsKaplan E, Heimer R. HIV Incidence Among New Haven Needle Exchange Participants JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 10: 175-176. PMID: 7552482, DOI: 10.1097/00042560-199510020-00010.
• The replyHeimer R. The reply The American Journal Of Medicine 1995, 98: 597-598. DOI: 10.1016/s0002-9343(99)80026-6.
• A circulation theory of needle exchangeKaplan E, Heimer R. A circulation theory of needle exchange AIDS 1994, 8: 567-574. PMID: 8060540, DOI: 10.1097/00002030-199405000-00001.
• HIV incidence among needle exchange participants: estimates from syringe tracking and testing data.Kaplan E, Heimer R. HIV incidence among needle exchange participants: estimates from syringe tracking and testing data. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1994, 7: 182-9. PMID: 8301530.
• Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, ConnecticutHeimer R, Kaplan E, Khoshnood K, Jariwala B, Cadman E. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut The American Journal Of Medicine 1993, 95: 214-220. PMID: 8356986, DOI: 10.1016/0002-9343(93)90263-o.
• HIV DNA and antibodies in syringes from injecting drug users, a comparison of detection techniquesMyers S, Heimer R, Liu D, Henrard D. HIV DNA and antibodies in syringes from injecting drug users, a comparison of detection techniques AIDS 1993, 7: 925-932. PMID: 8357554, DOI: 10.1097/00002030-199307000-00004.
• What Happened to HIV Transmission among Drug Injectors in New Haven?Kaplan E, Heimer R. What Happened to HIV Transmission among Drug Injectors in New Haven? Chance 1993, 6: 9-14. DOI: 10.1080/09332480.1993.10542355.
• Prevalence of HIV-Infected Syringes during a Syringe-Exchange ProgramHeimer R, Kaplan E, Cadman E. Prevalence of HIV-Infected Syringes during a Syringe-Exchange Program New England Journal Of Medicine 1992, 327: 1883-1884. PMID: 1448131, DOI: 10.1056/nejm199212243272613.
• RNA-directed actions of 5-fluorouridine in hemin stimulated K-562 erythroleukemia cells.Heimer R, Sartorelli A. RNA-directed actions of 5-fluorouridine in hemin stimulated K-562 erythroleukemia cells. Cancer Biochemistry Biophysics 1992, 12: 221-39. PMID: 1423209.
• A model-based estimate of HIV infectivity via needle sharing.Kaplan E, Heimer R. A model-based estimate of HIV infectivity via needle sharing. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1992, 5: 1116-8. PMID: 1403641.
• HIV prevalence among intravenous drug users: model-based estimates from New Haven's legal needle exchange.Kaplan E, Heimer R. HIV prevalence among intravenous drug users: model-based estimates from New Haven's legal needle exchange. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1992, 5: 163-9. PMID: 1732509.
• Reductions in γ-GIobin mRNA Levels Restricted to the Cytoplasm of 5-Fluorouridine Treated K-562 Human Erythroleukemia CellsHeimer R, Sartorelli A. Reductions in γ-GIobin mRNA Levels Restricted to the Cytoplasm of 5-Fluorouridine Treated K-562 Human Erythroleukemia Cells Oncology Research Featuring Preclinical And Clinical Cancer Therapeutics 1990, 2: 45-53. PMID: 2369550, DOI: 10.3727/095535490820874759.
• RNA polymerase II transcripts as targets for 5-fluorouridine cytotoxicity: antagonism of 5-fluorouridine actions by α-amanitinHeimer R, Sartorelli A. RNA polymerase II transcripts as targets for 5-fluorouridine cytotoxicity: antagonism of 5-fluorouridine actions by α-amanitin Cancer Chemotherapy And Pharmacology 1989, 24: 80-86. PMID: 2731315, DOI: 10.1007/bf00263125.
• Levels of thymidylate synthetase during normal culture growth of L1210 cells.Cadman E, Heimer R. Levels of thymidylate synthetase during normal culture growth of L1210 cells. Cancer Research 1986, 46: 1195-8. PMID: 3943093.
• Modulation of 5-Fluorouracil Cytotoxicity by Intracellular Pools of 5-Phosphoribosyl-1-Pyrophosphate (PRPP)Benz C, Heimer R, Cadman E. Modulation of 5-Fluorouracil Cytotoxicity by Intracellular Pools of 5-Phosphoribosyl-1-Pyrophosphate (PRPP) 1986, 93-105. DOI: 10.1007/978-1-4613-2331-0_5.
• Lack of enhanced cytotoxicity of cultured L1210 cells using folinic acid in combination with sequential methotrexate and fluorouracilDanhauser L, Heimer R, Cadman E. Lack of enhanced cytotoxicity of cultured L1210 cells using folinic acid in combination with sequential methotrexate and fluorouracil Cancer Chemotherapy And Pharmacology 1985, 15: 214-219. PMID: 3876889, DOI: 10.1007/bf00263888.
• Modulation of fluoropyrimidine metabolism in L1210 cells by l-alanosineHeimer R, Goldberg D, Cadman E. Modulation of fluoropyrimidine metabolism in L1210 cells by l-alanosine Biochemical Pharmacology 1983, 32: 199-206. PMID: 6870949, DOI: 10.1016/0006-2952(83)90544-0.
• Analysis of the thymidylate synthetase ternary complex by high-performance liquid steric exclusion chromatographyHeimer R, Cadman E. Analysis of the thymidylate synthetase ternary complex by high-performance liquid steric exclusion chromatography Analytical Biochemistry 1981, 118: 322-327. PMID: 7337229, DOI: 10.1016/0003-2697(81)90589-3.
• Effect of de novo purine synthesis inhibitors on 5-fluorouracil metabolism and cytotoxicityCadman E, Benz C, Heimer R, O'Shaughnessy J. Effect of de novo purine synthesis inhibitors on 5-fluorouracil metabolism and cytotoxicity Biochemical Pharmacology 1981, 30: 2469-2472. PMID: 21043247, DOI: 10.1016/0006-2952(81)90343-9.
• The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells.Cadman E, Heimer R, Benz C. The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells. Journal Of Biological Chemistry 1981, 256: 1695-1704. PMID: 6161926, DOI: 10.1016/s0021-9258(19)69863-7.
• Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug SynergismCadman E, Heimer R, Davis L. Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug Synergism Science 1979, 205: 1135-1137. PMID: 472732, DOI: 10.1126/science.472732.
• Pyrazofurin enhancement of 5-azacytidine antitumor activity in L5178Y and human leukemia cells.Cadman E, Eiferman F, Heimer R, Davis L. Pyrazofurin enhancement of 5-azacytidine antitumor activity in L5178Y and human leukemia cells. Cancer Research 1978, 38: 4610-7. PMID: 82479.